Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra for Early Stage TNBC and ER-low Breast Cancer
NCT06710197Phase 2Withdrawn
- Sponsor
- University Health Network
- Start
- Mar 2025
- Primary completion
- Feb 2026
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of anakinra in breast cancer, sponsored by University Health Network. Planned start Mar 2025; status: withdrawn.
02
Drugs
anakinra
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06710197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06710197.